
ACADIA Pharmaceuticals ACAD
$ 27.08
-0.26%
Annual report 2024
added 02-27-2025
ACADIA Pharmaceuticals Cash Conversion Cycle 2011-2025 | ACAD
Annual Cash Conversion Cycle ACADIA Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 257 | - | - | 184 | 62.7 | 24.4 | 63.3 | -45 | 172 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 257 | -45 | 103 |
Quarterly Cash Conversion Cycle ACADIA Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -158 | - | - | 97.7 | 200 | 43.6 | 142 | 100 | 100 | 36.4 | 90.6 | 77.4 | 47.6 | 33.2 | 1.24 | 12.1 | 45.2 | 40 | 62.3 | 64.8 | -15.3 | 36.3 | -107 | -93.2 | 69.4 | 45 | 102 | 5.55 K | 67.3 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 67.3 K | -158 | 2.74 K |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Arbutus Biopharma Corporation
ABUS
|
31.5 | $ 4.85 | 2.87 % | $ 805 M | ||
|
Aclaris Therapeutics
ACRS
|
-881 | $ 3.21 | -1.23 % | $ 248 M | ||
|
Aptevo Therapeutics
APVO
|
-47.4 | $ 1.06 | -6.64 % | $ 293 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-2.85 K | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
166 | $ 26.2 | 3.68 % | $ 1.27 B | ||
|
Anika Therapeutics
ANIK
|
270 | $ 9.59 | 0.31 % | $ 141 M | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
Catalyst Biosciences
CBIO
|
391 | $ 13.48 | -4.36 % | $ 887 M | ||
|
Axon Enterprise
AXON
|
86.2 | $ 549.1 | -2.69 % | $ 41.6 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.15 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
174 | $ 2.4 | 4.34 % | $ 15.1 M | ||
|
AstraZeneca PLC
AZN
|
-58 | $ 91.04 | 1.35 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
149 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
209 | $ 11.23 | -2.69 % | $ 726 M | ||
|
Biogen
BIIB
|
387 | $ 174.94 | 0.48 % | $ 25.5 B | ||
|
Abeona Therapeutics
ABEO
|
387 | $ 5.07 | -5.5 % | $ 108 M | ||
|
Celldex Therapeutics
CLDX
|
-6.08 K | $ 27.11 | -1.47 % | $ 1.75 M | ||
|
ADiTx Therapeutics
ADTX
|
-4.31 K | $ 1.66 | -25.84 % | $ 21.9 K | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
214 | - | -7.31 % | $ 87 M | ||
|
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M | ||
|
Завод ДИОД
DIOD
|
-32.7 | - | - | - | ||
|
Фармсинтез
LIFE
|
-15.9 | - | - | - |